Abstract

COVID-19 vaccines have been largely debated by the press. To understand how mainstream and alternative media debated vaccines, we introduce a paradigm reconstructing time-evolving narrative frames via cognitive networks and natural language processing. We study Italian news articles massively re-shared on Facebook/Twitter (up to 5 million times), covering 5745 vaccine-related news from 17 news outlets over 8 months. We find consistently high trust/anticipation and low disgust in the way mainstream sources framed “vaccine/vaccino”. These emotions were crucially missing in alternative outlets. News titles from alternative sources framed “AstraZeneca” with sadness, absent in mainstream titles. Initially, mainstream news linked mostly “Pfizer” with side effects (e.g. “allergy”, “reaction”, “fever”). With the temporary suspension of “AstraZeneca”, negative associations shifted: Mainstream titles prominently linked “AstraZeneca” with side effects, while “Pfizer” underwent a positive valence shift, linked to its higher efficacy. Simultaneously, thrombosis and fearful conceptual associations entered the frame of vaccines, while death changed context, i.e. rather than hopefully preventing deaths, vaccines could be reported as potential causes of death, increasing fear. Our findings expose crucial aspects of the emotional narratives around COVID-19 vaccines adopted by the press, highlighting the need to understand how alternative and mainstream media report vaccination news.

Details

Title
Emotional profiling and cognitive networks unravel how mainstream and alternative press framed AstraZeneca, Pfizer and COVID-19 vaccination campaigns
Author
Semeraro, Alfonso 1 ; Vilella, Salvatore 1 ; Ruffo, Giancarlo 1 ; Stella, Massimo 2 

 University of Turin, Computer Science Department, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580) 
 University of Exeter, CogNosco Lab, Department of Computer Science, Exeter, UK (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2705977285
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.